BATTIPAGLIA, GIORGIA
BATTIPAGLIA, GIORGIA
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study.
2010 Rinaldi, Cr; Rinaldi, P; Gemei, M; Grimaldi, F; Battipaglia, G; Del Vecchio, L; Martino, B; Specchia, G; Candoni, A; Gugliotta, L; Vannucchi, Am; Barbui, T; Pane, Fabrizio
Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
2012 Battipaglia, G; Avilia, S; Morelli, E; Caranci, Ferdinando; Perna, F; Camera, Andrea
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
2020 Debureaux, P. -E.; Labopin, M.; Mamez, A. -C.; Lapusan, S.; Isnard, F.; Adaeva, R.; Bonnin, A.; Hirsch, P.; Delhommeau, F.; Battipaglia, G.; Dulery, R.; Malard, F.; Vekhoff, A.; Mohty, M.; Legrand, O.; Brissot, E.
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
2020 Paccoud, O.; Guitard, J.; Labopin, M.; Surgers, L.; Malard, F.; Battipaglia, G.; Dulery, R.; Hennequin, C.; Mohty, M.; Brissot, E.
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies
2020 Peric, Z.; Mohty, R.; Bastos, J.; Brissot, E.; Battipaglia, G.; Belhocine, R.; Sestili, S.; Giannotti, F.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Lapusan, S.; Isnard, F.; Labopin, M.; Bonnin, A.; Mediavilla, C.; Rubio, M. -T.; Ruggeri, A.; Dulery, R.; Malard, F.; Mohty, M.
Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes
2020 Stocker, N.; Labopin, M.; Boussen, I.; Paccoud, O.; Bonnin, A.; Malard, F.; Amiel, C.; Gozlan, J.; Battipaglia, G.; Dulery, R.; Giannotti, F.; Ruggeri, A.; Gaugler, B.; Mohty, M.; Brissot, E.
Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group
2020 Polomeni, A.; Bompoint, C.; Labopin, M.; Badoglio, M.; Battipaglia, G.; Eeltink, C.; Liptrott, S. J.; Babik, A.; Murray, J.; Stringer, J.
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center experience
2020 Sestili, S.; Eder, S.; Belhocine, R.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Banet, A.; van de Wyngaert, Z.; Paviglianiti, A.; Ledraa, T.; Bonin, A.; Mohty, M.; Malard, F.
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
2020 Marini, C.; Brissot, E.; Bazarbachi, A.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Bannet, A.; van de Wiegert, Z.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Labopin, M.; Bonnin, A.; Ruggeri, A.; Malard, F.; Mohty, M.
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients
2020 Polverelli, N.; Tura, P.; Battipaglia, G.; Malagola, M.; Bernardi, S.; Gandolfi, L.; Zollner, T.; Zanaglio, C.; Farina, M.; Morello, E.; Turra, A.; Mohty, M.; Russo, D.
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT
2019 Battipaglia, G.; Boumendil, A.; Labopin, M.; Ciceri, F.; Tischer, J.; Stelljes, M.; Ehninger, G.; Beelen, D.; Finke, J.; Van Lint, M. T.; Eder, M.; Afanasyev, B.; Fanin, R.; Mohty, M.; Ruggeri, A.; Nagler, A.
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: A report of the EBMT Acute Leukemia Working Party
2019 Bazarbachi, A.; Labopin, M.; Battipaglia, G.; Djabali, A.; Passweg, J.; Socie, G.; Forcade, E.; Blaise, D.; Chevallier, P.; Orvain, C.; Cornelissen, J. J.; Arcese, W.; Chantepie, S.; Hashaishi, K.; Cheikh, J. E.; Medinger, M.; Esteve, J.; Nagler, A.; Mohty, M.
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation
2019 Stocker, N.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Sestili, S.; Paviglianiti, A.; Ledraa, T.; Mohty, R.; Bazarbachi, A.; Belhocine, R.; Vekhoff, A.; Ruggeri, A.; Mohty, M.; Malard, F.
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
2019 Garnache-Ottou, F.; Vidal, C.; Biichle, S.; Renosi, F.; Poret, E.; Pagadoy, M.; Desmarets, M.; Roggy, A.; Seilles, E.; Soret, L.; Schillinger, F.; Puyraimond, S.; Petrella, T.; Preudhomme, C.; Roumier, C.; Macintyre, E. A.; Harrivel, V.; Desbrosses, Y.; Gruson, B.; Genevieve, F.; Thepot, S.; Drebit, Y.; Leguay, T.; Gros, F. -X.; Lechevalier, N.; Saussoy, P.; Salaun, V.; Cornet, E.; Benseddik, Z.; Veyrat-Masson, R.; Wagner-Ballon, O.; Salanoubat, C.; Maynadie, M.; Guy, J.; Caillot, D.; Jacob, M. -C.; Cahn, J. -Y.; Gressin, R.; Rose, J.; Quesnel, B.; Guerin, E.; Trimoreau, F.; Feuillard, J.; Gourin, M. -P.; Plesa, A.; Baseggio, L.; Arnoux, I.; Vey, N.; Blaise, D.; Lacroix, R.; Arnoulet, C.; Benet, B.; Dorvaux, V.; Bret, C.; Drenou, B.; Debliquis, A.; Latger-Cannard, V.; Bonmati, C.; Bene, M. -C.; Peterlin, P.; Ticchioni, M.; Rohrlich, P. -S.; Arnaud, A.; Wickenhauser, S.; Bardet, V.; Brechignac, S.; Papoular, B.; Raggueneau, V.; Vargaftig, J.; Letestu, R.; Lusina, D.; Braun, T.; Foissaud, V.; Tamburini, J.; Bennani, H.; Freynet, N.; Cordonnier, C.; Le Garff-Tavernier, M.; Jacques, N.; Maloum, K.; Roos-Weil, D.; Bouscary, D.; Asnafi, V.; Lhermitte, L.; Suarez, F.; Lengline, E.; Feger, F.; Battipaglia, G.; Mohty, M.; Bouyer, S.; Ghoual, O.; Dindinaud, E.; Basle, C.; Puyade, M.; Lafon, C.; Fest, T.; Roussel, M.; Cahu, X.; Bera, E.; Daliphard, S.; Jardin, F.; Campos, L.; Solly, F.; Guyotat, D.; Galoisy, A. -C.; Eischen, A.; Mayeur-Rousse, C.; Guffroy, B.; Recher, C.; Loosveld, M.; Garnier, A.; Barlogis, V.; Rosenthal, M. A.; Brun, S.; Contentin, N.; Maury, S.; Callanan, M.; Lefebvre, C.; Maillard, N.; Okamba, P.; Ferrand, C.; Adotevi, O.; Saas, P.; Angelot-Delettre, F.; Binda, D.; Deconinck, E.
Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation
2019 Mohty, R.; Brissot, E.; Battipaglia, G.; Ruggeri, A.; Dulery, R.; Bonnin, A.; Mediavilla, C.; Sestili, S.; Belhocine, R.; Vekhoff, A.; Ledraa, T.; Lapusan, C. S.; Adaeva, R.; Isnard, F.; Legrand, O.; Mohty, M.; Malard, F.
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
2019 Battipaglia, G.; Labopin, M.; Kroger, N.; Vitek, A.; Afanasyev, B.; Hilgendorf, I.; Schetelig, J.; Ganser, A.; Blaise, D.; Itala-Remes, M.; Passweg, J. R.; Bonifazi, F.; Finke, J.; Ruggeri, A.; Nagler, A.; Mohty, M.
Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update
2019 Battipaglia, G.; Massoud, R.; Ahmed, S. O.; Legrand, O.; El Cheikh, J.; Youniss, R.; Aljurf, M.; Mohty, M.; Bazarbachi, A.
CD34+-selected stem cell “Boost” for poor graft function after allogeneic hematopoietic stem cell transplantation
2019 Mohty, R.; Brissot, E.; Battipaglia, G.; Ruggeri, A.; Sestili, S.; Mediavilla, C.; Belhocine, R.; Dulery, R.; Mohty, M.; Malard, F.
Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria
2019 Battipaglia, G.; Malard, F.; Rubio, M. T.; Ruggeri, A.; Mamez, A. C.; Brissot, E.; Giannotti, F.; Dulery, R.; Joly, A. C.; Baylatry, M. T.; Kossmann, M. J.; Tankovic, J.; Beaugerie, L.; Sokol, H.; Mohty, M.
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation
2019 Dulery, R.; Bastos, J.; Paviglianiti, A.; Malard, F.; Brissot, E.; Battipaglia, G.; Mediavilla, C.; Giannotti, F.; Banet, A.; de Wyngaert, Z. V.; Ledraa, T.; Belhocine, R.; Sestili, S.; Adaeva, R.; Lapusan, S.; Isnard, F.; Legrand, O.; Vekhoff, A.; Rubio, M. -T.; Ruggeri, A.; Mohty, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study. | 1.1 Articolo in rivista | 2010 | Rinaldi, Cr; Rinaldi, P; Gemei, M; Grimaldi, F; Battipaglia, G; Del Vecchio, L; Martino, B; Specchia, G; Candoni, A; Gugliotta, L; Vannucchi, Am; Barbui, T; Pane, Fabrizio | |
| Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). | 1.1 Articolo in rivista | 2012 | Battipaglia, G; Avilia, S; Morelli, E; Caranci, Ferdinando; Perna, F; Camera, Andrea | |
| Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia | 1.1 Articolo in rivista | 2020 | Debureaux, P. -E.; Labopin, M.; Mamez, A. -C.; Lapusan, S.; Isnard, F.; Adaeva, R.; Bonnin, A.; Hirsch, P.; Delhommeau, F.; Battipaglia, G.; Dulery, R.; Malard, F.; Vekhoff, A.; Mohty, M.; Legrand, O.; Brissot, E. | |
| Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting | 1.1 Articolo in rivista | 2020 | Paccoud, O.; Guitard, J.; Labopin, M.; Surgers, L.; Malard, F.; Battipaglia, G.; Dulery, R.; Hennequin, C.; Mohty, M.; Brissot, E. | |
| Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies | 1.1 Articolo in rivista | 2020 | Peric, Z.; Mohty, R.; Bastos, J.; Brissot, E.; Battipaglia, G.; Belhocine, R.; Sestili, S.; Giannotti, F.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Lapusan, S.; Isnard, F.; Labopin, M.; Bonnin, A.; Mediavilla, C.; Rubio, M. -T.; Ruggeri, A.; Dulery, R.; Malard, F.; Mohty, M. | |
| Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes | 1.1 Articolo in rivista | 2020 | Stocker, N.; Labopin, M.; Boussen, I.; Paccoud, O.; Bonnin, A.; Malard, F.; Amiel, C.; Gozlan, J.; Battipaglia, G.; Dulery, R.; Giannotti, F.; Ruggeri, A.; Gaugler, B.; Mohty, M.; Brissot, E. | |
| Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group | 1.1 Articolo in rivista | 2020 | Polomeni, A.; Bompoint, C.; Labopin, M.; Badoglio, M.; Battipaglia, G.; Eeltink, C.; Liptrott, S. J.; Babik, A.; Murray, J.; Stringer, J. | |
| Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center experience | 1.1 Articolo in rivista | 2020 | Sestili, S.; Eder, S.; Belhocine, R.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Banet, A.; van de Wyngaert, Z.; Paviglianiti, A.; Ledraa, T.; Bonin, A.; Mohty, M.; Malard, F. | |
| Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation | 1.1 Articolo in rivista | 2020 | Marini, C.; Brissot, E.; Bazarbachi, A.; Dulery, R.; Sestili, S.; Battipaglia, G.; Mediavilla, C.; Paviglianiti, A.; Belhocine, R.; Isnard, F.; Lapusan, S.; Adaeva, R.; Bannet, A.; van de Wiegert, Z.; Vekhoff, A.; Ledraa, T.; Legrand, O.; Labopin, M.; Bonnin, A.; Ruggeri, A.; Malard, F.; Mohty, M. | |
| Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients | 1.1 Articolo in rivista | 2020 | Polverelli, N.; Tura, P.; Battipaglia, G.; Malagola, M.; Bernardi, S.; Gandolfi, L.; Zollner, T.; Zanaglio, C.; Farina, M.; Morello, E.; Turra, A.; Mohty, M.; Russo, D. | |
| Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT | 1.1 Articolo in rivista | 2019 | Battipaglia, G.; Boumendil, A.; Labopin, M.; Ciceri, F.; Tischer, J.; Stelljes, M.; Ehninger, G.; Beelen, D.; Finke, J.; Van Lint, M. T.; Eder, M.; Afanasyev, B.; Fanin, R.; Mohty, M.; Ruggeri, A.; Nagler, A. | |
| Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: A report of the EBMT Acute Leukemia Working Party | 1.1 Articolo in rivista | 2019 | Bazarbachi, A.; Labopin, M.; Battipaglia, G.; Djabali, A.; Passweg, J.; Socie, G.; Forcade, E.; Blaise, D.; Chevallier, P.; Orvain, C.; Cornelissen, J. J.; Arcese, W.; Chantepie, S.; Hashaishi, K.; Cheikh, J. E.; Medinger, M.; Esteve, J.; Nagler, A.; Mohty, M. | |
| Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation | 1.1 Articolo in rivista | 2019 | Stocker, N.; Dulery, R.; Battipaglia, G.; Brissot, E.; Mediavilla, C.; Sestili, S.; Paviglianiti, A.; Ledraa, T.; Mohty, R.; Bazarbachi, A.; Belhocine, R.; Vekhoff, A.; Ruggeri, A.; Mohty, M.; Malard, F. | |
| How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? | 1.1 Articolo in rivista | 2019 | Garnache-Ottou, F.; Vidal, C.; Biichle, S.; Renosi, F.; Poret, E.; Pagadoy, M.; Desmarets, M.; Roggy, A.; Seilles, E.; Soret, L.; Schillinger, F.; Puyraimond, S.; Petrella, T.; Preudhomme, C.; Roumier, C.; Macintyre, E. A.; Harrivel, V.; Desbrosses, Y.; Gruson, B.; Genevieve, F.; Thepot, S.; Drebit, Y.; Leguay, T.; Gros, F. -X.; Lechevalier, N.; Saussoy, P.; Salaun, V.; Cornet, E.; Benseddik, Z.; Veyrat-Masson, R.; Wagner-Ballon, O.; Salanoubat, C.; Maynadie, M.; Guy, J.; Caillot, D.; Jacob, M. -C.; Cahn, J. -Y.; Gressin, R.; Rose, J.; Quesnel, B.; Guerin, E.; Trimoreau, F.; Feuillard, J.; Gourin, M. -P.; Plesa, A.; Baseggio, L.; Arnoux, I.; Vey, N.; Blaise, D.; Lacroix, R.; Arnoulet, C.; Benet, B.; Dorvaux, V.; Bret, C.; Drenou, B.; Debliquis, A.; Latger-Cannard, V.; Bonmati, C.; Bene, M. -C.; Peterlin, P.; Ticchioni, M.; Rohrlich, P. -S.; Arnaud, A.; Wickenhauser, S.; Bardet, V.; Brechignac, S.; Papoular, B.; Raggueneau, V.; Vargaftig, J.; Letestu, R.; Lusina, D.; Braun, T.; Foissaud, V.; Tamburini, J.; Bennani, H.; Freynet, N.; Cordonnier, C.; Le Garff-Tavernier, M.; Jacques, N.; Maloum, K.; Roos-Weil, D.; Bouscary, D.; Asnafi, V.; Lhermitte, L.; Suarez, F.; Lengline, E.; Feger, F.; Battipaglia, G.; Mohty, M.; Bouyer, S.; Ghoual, O.; Dindinaud, E.; Basle, C.; Puyade, M.; Lafon, C.; Fest, T.; Roussel, M.; Cahu, X.; Bera, E.; Daliphard, S.; Jardin, F.; Campos, L.; Solly, F.; Guyotat, D.; Galoisy, A. -C.; Eischen, A.; Mayeur-Rousse, C.; Guffroy, B.; Recher, C.; Loosveld, M.; Garnier, A.; Barlogis, V.; Rosenthal, M. A.; Brun, S.; Contentin, N.; Maury, S.; Callanan, M.; Lefebvre, C.; Maillard, N.; Okamba, P.; Ferrand, C.; Adotevi, O.; Saas, P.; Angelot-Delettre, F.; Binda, D.; Deconinck, E. | |
| Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation | 1.1 Articolo in rivista | 2019 | Mohty, R.; Brissot, E.; Battipaglia, G.; Ruggeri, A.; Dulery, R.; Bonnin, A.; Mediavilla, C.; Sestili, S.; Belhocine, R.; Vekhoff, A.; Ledraa, T.; Lapusan, C. S.; Adaeva, R.; Isnard, F.; Legrand, O.; Mohty, M.; Malard, F. | |
| Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation | 1.1 Articolo in rivista | 2019 | Battipaglia, G.; Labopin, M.; Kroger, N.; Vitek, A.; Afanasyev, B.; Hilgendorf, I.; Schetelig, J.; Ganser, A.; Blaise, D.; Itala-Remes, M.; Passweg, J. R.; Bonifazi, F.; Finke, J.; Ruggeri, A.; Nagler, A.; Mohty, M. | |
| Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update | 1.1 Articolo in rivista | 2019 | Battipaglia, G.; Massoud, R.; Ahmed, S. O.; Legrand, O.; El Cheikh, J.; Youniss, R.; Aljurf, M.; Mohty, M.; Bazarbachi, A. | |
| CD34+-selected stem cell “Boost” for poor graft function after allogeneic hematopoietic stem cell transplantation | 1.1 Articolo in rivista | 2019 | Mohty, R.; Brissot, E.; Battipaglia, G.; Ruggeri, A.; Sestili, S.; Mediavilla, C.; Belhocine, R.; Dulery, R.; Mohty, M.; Malard, F. | |
| Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria | 1.1 Articolo in rivista | 2019 | Battipaglia, G.; Malard, F.; Rubio, M. T.; Ruggeri, A.; Mamez, A. C.; Brissot, E.; Giannotti, F.; Dulery, R.; Joly, A. C.; Baylatry, M. T.; Kossmann, M. J.; Tankovic, J.; Beaugerie, L.; Sokol, H.; Mohty, M. | |
| Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation | 1.1 Articolo in rivista | 2019 | Dulery, R.; Bastos, J.; Paviglianiti, A.; Malard, F.; Brissot, E.; Battipaglia, G.; Mediavilla, C.; Giannotti, F.; Banet, A.; de Wyngaert, Z. V.; Ledraa, T.; Belhocine, R.; Sestili, S.; Adaeva, R.; Lapusan, S.; Isnard, F.; Legrand, O.; Vekhoff, A.; Rubio, M. -T.; Ruggeri, A.; Mohty, M. |